Literature DB >> 21370045

Mouse and other rodent models of C to U RNA editing.

Valerie Blanc1, Nicholas O Davidson.   

Abstract

Substitutional RNA editing represents an important posttranscriptional enzymatic pathway for increasing genetic plasticity by permitting production of different translation products from a single genomically encoded template. One of the best-characterized examples in mammals is C to U deamination of the nuclear apolipoprotein B (apoB) mRNA. ApoB mRNA undergoes a single, site-specific cytidine deamination event yielding an edited transcript that results in tissue-specific translation of two distinct isoforms, referred to as apoB100 and apoB48. Tissue- and site-specific cytidine deamination of apoB mRNA is mediated by an incompletely characterized holoenzyme containing a minimal core complex consisting of an RNA-specific cytidine deaminase, Apobec-1 and a requisite cofactor, apobec-1 complementation factor (ACF). The underlying biochemical and genetic mechanisms regulating tissue-specific apoB mRNA editing have been accelerated through development and characterization of physiological rodent models as well as knockout and transgenic animal strains.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21370045      PMCID: PMC3608419          DOI: 10.1007/978-1-61779-018-8_7

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  37 in total

1.  The db/db mouse, a model for diabetic dyslipidemia: molecular characterization and effects of Western diet feeding.

Authors:  K Kobayashi; T M Forte; S Taniguchi; B Y Ishida; K Oka; L Chan
Journal:  Metabolism       Date:  2000-01       Impact factor: 8.694

2.  Follicular cells of the thyroid gland require Pax8 gene function.

Authors:  A Mansouri; K Chowdhury; P Gruss
Journal:  Nat Genet       Date:  1998-05       Impact factor: 38.330

3.  Molecular cloning of apobec-1 complementation factor, a novel RNA-binding protein involved in the editing of apolipoprotein B mRNA.

Authors:  A Mehta; M T Kinter; N E Sherman; D M Driscoll
Journal:  Mol Cell Biol       Date:  2000-03       Impact factor: 4.272

4.  Involvement of T3Ralpha- and beta-receptor subtypes in mediation of T3 functions during postnatal murine intestinal development.

Authors:  M Plateroti; O Chassande; A Fraichard; K Gauthier; J N Freund; J Samarut; M Kedinger
Journal:  Gastroenterology       Date:  1999-06       Impact factor: 22.682

5.  Targeted deletion of the murine apobec-1 complementation factor (acf) gene results in embryonic lethality.

Authors:  Valerie Blanc; Jeffrey O Henderson; Elizabeth P Newberry; Susan Kennedy; Jianyang Luo; Nicholas O Davidson
Journal:  Mol Cell Biol       Date:  2005-08       Impact factor: 4.272

6.  Apolipoprotein B mRNA editing and apolipoprotein gene expression in the liver of hyperinsulinemic fatty Zucker rats: relationship to very low density lipoprotein composition.

Authors:  M B Elam; M A von Wronski; L Cagen; F Thorngate; P Kumar; M Heimberg; H G Wilcox
Journal:  Lipids       Date:  1999-08       Impact factor: 1.880

7.  Inhibition of N-linked glycosylation results in retention of intracellular apo[a] in hepatoma cells, although nonglycosylated and immature forms of apolipoprotein[a] are competent to associate with apolipoprotein B-100 in vitro.

Authors:  D K Bonen; F Nassir; A M Hausman; N O Davidson
Journal:  J Lipid Res       Date:  1998-08       Impact factor: 5.922

8.  Doxycycline-mediated quantitative and tissue-specific control of gene expression in transgenic mice.

Authors:  A Kistner; M Gossen; F Zimmermann; J Jerecic; C Ullmer; H Lübbert; H Bujard
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-01       Impact factor: 11.205

9.  Insulin increases expression of apobec-1, the catalytic subunit of the apolipoprotein B mRNA editing complex in rat hepatocytes.

Authors:  M A von Wronski; K I Hirano; L M Cagen; H G Wilcox; R Raghow; F E Thorngate; M Heimberg; N O Davidson; M B Elam
Journal:  Metabolism       Date:  1998-07       Impact factor: 8.694

10.  Metabolic regulation of apoB mRNA editing is associated with phosphorylation of APOBEC-1 complementation factor.

Authors:  David M Lehmann; Chad A Galloway; Mark P Sowden; Harold C Smith
Journal:  Nucleic Acids Res       Date:  2006-07-04       Impact factor: 16.971

View more
  5 in total

1.  Intestine-specific expression of Apobec-1 rescues apolipoprotein B RNA editing and alters chylomicron production in Apobec1 -/- mice.

Authors:  Valerie Blanc; Yan Xie; Jianyang Luo; Susan Kennedy; Nicholas O Davidson
Journal:  J Lipid Res       Date:  2012-09-19       Impact factor: 5.922

2.  Identification of protein disulfide isomerase 1 as a key isomerase for disulfide bond formation in apolipoprotein B100.

Authors:  Shiyu Wang; Shuin Park; Vamsi K Kodali; Jaeseok Han; Theresa Yip; Zhouji Chen; Nicholas O Davidson; Randal J Kaufman
Journal:  Mol Biol Cell       Date:  2014-12-17       Impact factor: 4.138

3.  Genome-wide analysis of differential RNA editing in epilepsy.

Authors:  Prashant Kumar Srivastava; Marta Bagnati; Andree Delahaye-Duriez; Jeong-Hun Ko; Maxime Rotival; Sarah R Langley; Kirill Shkura; Manuela Mazzuferi; Bénédicte Danis; Jonathan van Eyll; Patrik Foerch; Jacques Behmoaras; Rafal M Kaminski; Enrico Petretto; Michael R Johnson
Journal:  Genome Res       Date:  2017-03       Impact factor: 9.043

Review 4.  C-to-U RNA Editing: A Site Directed RNA Editing Tool for Restoration of Genetic Code.

Authors:  Sonali Bhakta; Toshifumi Tsukahara
Journal:  Genes (Basel)       Date:  2022-09-12       Impact factor: 4.141

5.  Genome-wide identification and functional analysis of Apobec-1-mediated C-to-U RNA editing in mouse small intestine and liver.

Authors:  Valerie Blanc; Eddie Park; Sabine Schaefer; Melanie Miller; Yiing Lin; Susan Kennedy; Anja M Billing; Hisham Ben Hamidane; Johannes Graumann; Ali Mortazavi; Joseph H Nadeau; Nicholas O Davidson
Journal:  Genome Biol       Date:  2014-06-19       Impact factor: 13.583

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.